المؤلفون: Passiglia F; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Reale ML; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Cetoretta V; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Parlagreco E; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Jacobs F; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Listì A; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Righi L; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Bironzo P; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Novello S; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy., Scagliotti GV; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy. Electronic address: giorgio.scagliotti@unito.it.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2021 Sep; Vol. 99, pp. 102256. Date of Electronic Publication: 2021 Jul 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Poly(ADP-ribose) Polymerase Inhibitors/*therapeutic use , Thoracic Neoplasms/*drug therapy, BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Humans ; Lung Neoplasms/drug therapy ; Mesothelioma, Malignant/drug therapy ; Pleural Neoplasms/drug therapy ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Randomized Controlled Trials as Topic ; Recombinational DNA Repair ; Thoracic Neoplasms/genetics